Once you need a pre-clinical trial, we are ready to provide full support in line with Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).
We routinely collect hundreds of biospecimens for global studies and strengthen them with valuable and precise clinical data. We believe our motto, “Quality is our DNA,” is a key success factor to accelerate the precision medicine programs for oncology, therapeutics, and infectious conditions. The BIOMEDICA CRO team has a unique combination of expertise and knowledge in the life sciences. The medical background of site managers guarantees that every project detail will be clearly communicated to primary investigators, while the scientific proficiency of lab and data managers secures a multi-step quality control.
Being customer-oriented, we tune our processes to be flexible and compliant to meet changing project requirements and ensure that we provide high-quality biospecimens on time and within budget.
We do not waste the research group’s valuable time — only 1–3 weeks are required to launch a prospective study after receiving your Purchase Order. This is the timeframe we typically need to prepare project documentation and collection kits, conduct training sessions with physicians and laboratory technicians involved in the study, and perform other related activities.

354000
HUMAN BIOSPECIMENS COLLECTED
Numerous projects sponsored by globally recognized pharmaceutical companies and diagnostic centers
50
PARTNERED CLINICAL SITES
No brokerage – only our partnered clinical sites with direct access to PIs
43000
RECRUITED PATIENTS
A broad range of indications including oncology, therapeutic areas, and infectious diseases
HUMAN BIOSPECIMENS COLLECTED
Numerous projects sponsored by globally recognized pharmaceutical companies and diagnostic centers
PARTNERED CLINICAL SITES
No brokerage – only our partnered clinical sites with direct access to PIs
RECRUITED PATIENTS
A broad range of indications, including oncology, therapeutic areas, and infectious diseases
CUSTOMERS' REVIEWS
What Our Customers Say
Learn what some of our customers have shared about working with us
Our study required the prospective recruitment of more than 200 Alzheimer's disease patients and healthy controls with customized biospecimen processing. BIOMEDICA CRO demonstrated outstanding flexibility in adapting their collection and processing workflow to our protocol while maintaining excellent communication throughout the project.
We ordered banked serum samples and FFPE tissue blocks from BIOMEDICA CRO's inventory for our early-stage biomarker development program. Beyond providing high-quality biospecimens, the team proactively suggested a more cost-efficient logistics solution that significantly reduced our shipping expenses. Their flexibility, responsiveness, and scientific understanding made them an excellent partner for a growing biotechnology company.
For several years, BIOMEDICA CRO has supported our prospective oncology research through monthly collections of matched tumor tissue and blood samples. Their consistency, reliability, and proactive communication have made them one of our preferred biospecimen providers.
The customized patient questionnaires and clinical documentation developed for our infectious disease study significantly simplified downstream data analysis. We particularly appreciated the team's willingness to adapt documentation according to our internal requirements. Also, strong ethical governance was one of the main reasons we selected BIOMEDICA CRO. The team's commitment to patient rights, informed consent, and regulatory compliance made them a trusted partner for our translational research program.
We sourced 30 atopic dermatitis and 20 psoriasis fresh frozen tissue specimens from BIOMEDICA CRO's inventory. The sample quality, documentation, and detailed clinical information exceeded our expectations and supported rapid study initiation.
Access to a broad spectrum of cardiovascular diagnoses was one of the key reasons we selected BIOMEDICA CRO. Their prospective recruitment program enabled the collection of blood samples according to our study protocol, with excellent project coordination from start to finish.
The consistency of plasma aliquoting and accompanying clinical information was outstanding. Every shipment (there were around 2000 vials per batch) arrived exactly as expected, allowing our laboratory to begin testing immediately. We are already planning additional orders.
Our project involved urine cell pellets and urine supernatant samples collection from 350 subjects. BIOMEDICA CRO demonstrated remarkable flexibility by implementing our customized processing protocol and logistics requirements without compromising turnaround times.
The extensive clinical annotation available for each gastrointestinal case greatly increased the value of the biospecimens. We successfully obtained more than one hundred IBD FFPE tissue blocks together with matched plasma samples for our translational research program.
Prospective collection of placenta tissue and matched maternal blood was exceptionally well organized. Coordinating this type of study requires considerable expertise, and BIOMEDICA CRO managed the project with impressive professionalism. Moreover, we highly appreciate BIOMEDICA CRO's commitment to ethical standards throughout every stage of the project.
We initiated a prospective study involving 100 patients with multiple sclerosis and 100 patients with mild cognitive impairment. Patient recruitment progressed according to plan, biospecimen quality remained consistently high, and communication throughout the project was excellent.
P.S. Recruitment started within just two weeks after we placed our order! We were kept regularly updated on the collection status throughout the study.
The level of flexibility demonstrated during protocol finalization was outstanding. BIOMEDICA CRO quickly adapted sample processing, labeling, and shipping procedures to align with our internal laboratory workflow.
After evaluating several biospecimen providers, we found BIOMEDICA CRO's pricing to be competitive and well justified considering the quality of the biospecimens, accompanying clinical data, and overall level of service. The availability of well-characterized normal donor plasma enabled us to complete assay validation much faster than anticipated. Sample traceability and documentation were maintained at every stage of the project.
International logistics were managed seamlessly despite strict transportation requirements. Every shipment arrived on time with complete documentation, allowing our laboratory to proceed without delays.
The breadth of BIOMEDICA CRO's biospecimen inventory allowed us to identify suitable patient cohorts within a very short timeframe. Their responsiveness significantly accelerated project initiation, and we received the requested biospecimens within just two weeks of placing our order. Thank you!
We especially appreciated the quality of the clinical annotation accompanying each biospecimen. The completeness of patient information substantially reduced additional data requests during our study.
Every aspect of project execution, from feasibility assessment to shipment coordination, was handled professionally. BIOMEDICA CRO consistently delivered according to agreed timelines while maintaining excellent communication.
The team's ability to organize customized processing workflows for our biospecimen collections made a significant difference to our project. Their scientific understanding and operational flexibility were highly appreciated.
Working with BIOMEDICA CRO has been a consistently positive experience. Their responsiveness, transparency, and commitment to delivering high-quality cancer biospecimens have made them a trusted research partner.
The quality of the isolated PBMCs fully met our expectations. Biospecimens arrived in a liquid nitrogen dry shipper in excellent condition, and post-arrival viability testing confirmed that the cells were suitable for our downstream functional assays. We greatly appreciated BIOMEDICA CRO's attention to processing quality and logistics.

Our mission
We contribute to world science by providing easy access to human biospecimens
Our vision
When it comes to quality, we never compromise. Our proprietary approach involves applying multi-step quality control processes to ensure that accurate and appropriate specimens are procured and distributed to our clients. Our services facilitate your research in an efficient and effective manner.
Meet our team
Management
We have brought together highly qualified professionals who do their best to support our customers and accelerate their scientific research.
Global supply of human biospecimens
Researchers from all over the world are in constant need of human biospecimens.
Our aim is to provide fast and easy access to the biospecimens you need through precise clinical data, validated processing protocols, reliable timelines, and continuous monitoring of clinical sites and principal investigators.
BIOMEDICA CRO collaborates with clients from leading research-investing countries, including the US, Canada, the UK, Germany, Japan, Italy, Switzerland, France, and many others.
We supply human biospecimens worldwide and continuously expand our client network, which includes pharmaceutical and biotechnology companies, diagnostic laboratories, R&D departments, biobanks, and specialized marketplaces.





Switzerland
United Kingdom
United States
France
Netherlands
Japan
Canada

Spain
Australia
Italy
Belgium
Denmark

Sweden
Ireland
Poland
Finland








